ATLANTA, Nov. 26, 2024 /PRNewswire/ -- UCB today announced it will present 32 abstracts from its expansive epilepsies research program at the American Epilepsy Society (AES) Annual Meeting ...

Praxis Precision (PRAX) Medicines announced that that it will present preclinical and clinical data from three of its epilepsy programs at the American Epilepsy Society, AES, Annual Meeting, being ...

ATLANTA, Nov. 26, 2024 /PRNewswire/ -- UCB today announced it will present 32 abstracts from its expansive epilepsies research program at the American Epilepsy Society (AES) Annual Meeting, December 6 ...

is proud to announce two upcoming presentations at the American Epilepsy Society 2024 Annual Meeting in Los Angeles, December 6-10, 2024. The Company’s presentation details are as follows ...

One aspect of this is that we involve residents in the development and delivery of staff training. Our care staffFind out more UK’s leading provider of epilepsy services. Epilepsy Society is the UK’s ...

Ltd., will present updated data on cenobamate, an anti-seizure medication, at the 2024 American Epilepsy Society (AES) Annual Meeting in Los Angeles, California, December 6-10, 2024. The company ...

Research carried out by Carers UK estimates the number of unpaid carers in the UK could be ... If you are a carer of someone with epilepsy, we offer help and support for you. At Epilepsy Society we ...

the UK, and Switzerland. Cenobamate is also being developed for commercialization by SK Biopharmaceuticals' partners in many other countries to meet the needs of patients living with epilepsy ...

“The pursuit of seizure freedom is a critical and often elusive goal for epilepsy patients,” said Louis Ferrari, BS, RPh, MBA, vice president, Medical Affairs at SK Life Science. “Our data ...